Scientists hunt for clues in COVID Patients' blood and secretions
NCT ID NCT04956445
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study collects blood and nasal secretions from up to 2,000 people with COVID-19 to learn why some get very sick while others recover easily. Researchers will also track long-term symptoms like fatigue and brain fog. No treatments are tested—the goal is to gather data to guide future countermeasures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could clarify why some people get severe COVID-19 and others don't, and help develop better treatments or vaccines.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead to any direct medical advances, and results may take years to apply.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOVIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tulane University Medical Center
RECRUITINGNew Orleans, Louisiana, 70112, United States
-
University Medical Center New Orleans
RECRUITINGNew Orleans, Louisiana, 70112, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can cord blood t cells be trained to stop viral infections after transplant?
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Can a new drug shield lungs from COVID-19's worst damage?